World's Best Scientists 2026 revealed!
Psychopharmacology
H-index 40

Psychopharmacology

0033-3158

Published by: Springer

https://www.springer.com/journal/213

Ranking & Metrics

Discipline name Position Best Scientists Publications D-Index
Psychology 153 277 303 28
Medicine 652 168 227 30

Additional Metrics

Number of Best Scientists*: 765
Documents by Best Scientists*: 712
Top 100 Ranked Scientists*: 16
SCIMAGO H-index: 218
SCIMAGO SJR: 1.157
Impact Factor: 3.3

Overview

Top Research Topics at Psychopharmacology?

The main research concerns discussed in the journal are Pharmacology, Internal medicine, Endocrinology, Anesthesia and Pharmacology toxicology. While Pharmacology is the focus of Psychopharmacology, it also provided insights into the studies of Haloperidol, Amphetamine and Antagonist. The journal concentrates on Internal medicine topics that focus on Dopamine, Agonist, Serotonin, Receptor and Dopamine receptor.

Research on Dopamine presented in the journal concerns the broader topic of Neuroscience. The study on Neuroscience featured in Psychopharmacology expounds on the topic of Prefrontal cortex in particular. The subject of Ethanol, which is connected to the field of Alcohol, serves as the foundation of the Endocrinology research featured in it.

Anesthesia research featured in Psychopharmacology incorporates concerns from various other topics such as Placebo and Nicotine. The Pharmacology toxicology works featured in the journal incorporate elements from Developmental psychology and Psychiatry. Developmental psychology study tackled is connected to the field of Audiology.

  • Pharmacology (37.01%)
  • Internal medicine (36.32%)
  • Endocrinology (34.03%)

What are the most cited papers published in the journal?

  • The tail suspension test: A new method for screening antidepressants in mice (2552 citations)
  • The use of a plus-maze to measure anxiety in the mouse (2173 citations)
  • The debate over dopamine’s role in reward: the case for incentive salience (1786 citations)

Research areas of the most cited articles at Psychopharmacology:

The main points discussed in the journal papers deal with Pharmacology, Internal medicine, Endocrinology, Anesthesia and Neuroscience. The journal publications facilitate discussions on Pharmacology that incorporate concepts from other fields like Amphetamine, Antagonist and Nicotine. The works on Internal medicine tackled in the journal articles bring together disciplines like Antidepressant and Ethanol.

What topics the last edition of the journal is best known for?

  • Internal medicine
  • Pharmacology
  • Diabetes mellitus

The previous edition focused in particular on these issues:

The journal mainly tackles studies in Internal medicine, Pharmacology, Endocrinology, Neuroscience and Clinical psychology. Issues in Internal medicine were discussed, taking into consideration concepts from other disciplines like Alcohol, Schizophrenia and Major depressive disorder. The journal explores topics in Schizophrenia which can be helpful for research in disciplines like Psychosis and Cognition.

The close relationship between Opioid and Anesthesia is one of the points of interest dissected in Pharmacology research. The featured Anesthesia studies mainly concentrate on Placebo but also cover areas of interest in Randomized controlled trial and Craving. While work presented in Psychopharmacology provided substantial information on Endocrinology, it also covered topics in Elevated plus maze and Impulsivity.

The most cited articles from the last journal are:

  • An experimental medicine study of the phosphodiesterase-4 inhibitor, roflumilast, on working memory-related brain activity and episodic memory in schizophrenia patients (18 citations)
  • Cognitive neuropsychological theory of antidepressant action: a modern-day approach to depression and its treatment (17 citations)
  • Cannabidiol: pharmacology and therapeutic targets (10 citations)

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

The top authors publishing in Psychopharmacology (based on the number of publications) are:

  • Trevor W. Robbins (147 papers) published 3 papers at the last edition, 1 more than at the previous edition,
  • Klaus A. Miczek (143 papers) absent at the last edition,
  • Philip J. Cowen (89 papers) published 1 paper at the last edition the same number as at the previous edition,
  • Mark A. Geyer (72 papers) absent at the last edition,
  • George F. Koob (70 papers) absent at the last edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Only papers with recognized affiliations are considered

The top affiliations publishing in Psychopharmacology (based on the number of publications) are:

  • National Institutes of Health (397 papers) published 4 papers at the last edition the same number as at the previous edition,
  • Harvard University (294 papers) published 1 paper at the last edition, 4 less than at the previous edition,
  • Yale University (286 papers) published 5 papers at the last edition the same number as at the previous edition,
  • University of Cambridge (276 papers) published 4 papers at the last edition, 1 more than at the previous edition,
  • National Institute on Drug Abuse (247 papers) published 6 papers at the last edition, 2 more than at the previous edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2021 edition, 2.39% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 12.23% were posted by at least one author from the top 10 institutions publishing in the journal. Another 4.59% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 15.90% of all publications and 67.28% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

  • Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
  • Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
  • Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
  • Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
  • Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.

Career Opportunities in Psychopharmacology

In addition to providing cutting-edge information on Psychopharmacology research, we also aim to help readers explore career opportunities in the field. Psychopharmacology related careers are as diverse as the collection of topics discussed in our journal. They include and are not limited to, careers in academia, pharmaceutical industries, clinical psychology, counseling, social work, school psychology, and more. An intriguing career path to consider in this field is school psychology, where the knowledge in psychopharmacology can greatly enhance the understanding of student behavior and facilitate the development of effective intervention strategies. Many prospective school psychologists often wonder "how long does it take to become a school psychologist in Maryland". It can take anywhere from six to nine years to become a fully licensed school psychologist and this includes obtaining a bachelor's degree, a master's degree, and completing an internship. Specific state requirements can vary, and it's advisable for those interested to research thoroughly. This practical application of psychopharmacology can relay opportunities to shape young minds and contribute significantly to society, making the field all the more rewarding. Conducting your own due diligence, understanding your personal interests, and being consistent in your efforts can lead to a fruitful career in psychopharmacology.

Top Publications

  • Chronic mild stress paradigm as a rat model of depression: facts, artifacts, and future perspectives

    Unknown

    (2022)
    166 Citations
  • Great Expectations: recommendations for improving the methodological rigor of psychedelic clinical trials

    (2022)
    139 Citations
  • Prescription psychostimulants for the treatment of stimulant use disorder: a systematic review and meta-analysis

    Vitor S Tardelli;Adam Bisaga;Felipe B Arcadepani;Gilberto Gerra

    (2020)
    134 Citations
  • Tripping on nothing: placebo psychedelics and contextual factors

    Jay A. Olson;Léah Suissa-Rocheleau;Michael Lifshitz;Amir Raz;Amir Raz

    (2020)
    130 Citations
  • Psychedelics for the treatment of depression, anxiety, and existential distress in patients with a terminal illness: a systematic review

    Nina Schimmel;Joost J Breeksema;Sanne Y Smith-Apeldoorn;Jolien Veraart

    (2021)
    102 Citations
  • Safety, tolerability, pharmacokinetics, and pharmacodynamics of low dose lysergic acid diethylamide (LSD) in healthy older volunteers.

    Neiloufar Family;Emeline L Maillet;Luke T J Williams;Erwin Krediet

    (2020)
    97 Citations
  • Prospective examination of synthetic 5-methoxy-N,N-dimethyltryptamine inhalation: effects on salivary IL-6, cortisol levels, affect, and non-judgment

    Malin V Uthaug;Rafael Lancelotta;Attila Szabo;Alan K Davis

    (2020)
    88 Citations
  • Cognitive neuropsychological theory of antidepressant action: a modern-day approach to depression and its treatment

    Beata R Godlewska;Catherine J Harmer

    (2021)
    87 Citations
  • The Watts Connectedness Scale: a new scale for measuring a sense of connectedness to self, others, and world

    (2022)
    81 Citations

Related Online Degrees & Career Pathways

Pursuing a medical degree in the USA opens doors to a variety of related online degrees and career options. For those interested in broader health sciences, exploring some of the highest paying jobs with biology degree can reveal rewarding alternatives in research, pharmaceuticals, and healthcare management.

Another growing field within healthcare is medical coding and billing. This area offers a blend of administrative medical knowledge with technical expertise. Understanding the differences between certifications, such as the ccs vs cpc certification, is crucial for career advancement and salary growth.

Interested individuals can learn more about starting a career in this field by exploring how to become a medical coder salary varies depending on certification and experience. However, it's important to weigh the pros and cons carefully. A detailed look at is medical billing and coding worth it offers insights into job stability, growth potential, and work environment.

Overall, these related pathways provide practical alternatives and complementary careers for those engaged with medical and healthcare studies, supported by flexible online education options.

Best Scientists Contributing to This Journal

Recently Published Articles